Nastech in Obesity Treatment Pact with Merck
627029
Shares of Nastech Pharmaceutical Co.  Inc. jumped as much as 43 percent on Monday after it said it  formed an alliance with Merck & Co. to develop its  appetite-regulating treatment for obesity.
738835
Merck & Co.  said on Thursday its $1.1 billion deal to buy Sirna Therapeutics Inc. cleared an antitrust hurdle and said the deal could close as early as the end of this month.
281269
Shares of Nastech Pharmaceutical Co. Inc. (NSTK.O: Quote, Profile, Research) jumped as much as 43 percent on Monday after it said it formed an alliance with Merck &amp; Co.
623767
Metabolic Pharmaceuticals, an Australian biotech group announced Monday that its new weight-loss drug, known as AOD9604 appears to help overweight people to burn fat and does not have any apparent side effects.
615158
A NEW &quot;miracle&quot; drug for obesity could prove central to the fortunes of manufacturer Sanofi-Aventis, if the French company is successful in bringing it to the market.
408786
Merck & Co. on Tuesday said it aims to seek U.S. approvals next year for drugs to treat HIV, cholesterol and insomnia and aims to have another four products in late-stage trials by mid-2007.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
249030
Sanofi-Aventis SA is withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States, the French drugmaker said on Friday.
522767
Arena Pharmaceuticals, Inc.   said on Monday that Merck & Co. Inc.  has  pulled out of a partnership to develop an experimental drug for  atherosclerosis after results from a mid-stage clinical trail.
155751
NEW YORK/WHITEHOUSE STATION, New Jersey  - Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and it aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
524945
The US Food and Drug Administration has granted fast-trackapproval to Tarceva (erlotinib) to treat advanced non-small cell lungcancer that has failed to respond to other therapy.
482801
A new obesity wonder drug, Acomplia (rimonabant), makes patients lose 10% of their body weight, according to clinical trials carried out by Sanofi-Aventis, the third largest pharmaceutical company in the world.
581751
THE REGION Idera Pharmaceuticals Inc. of Cambridge signed a drug-development deal with Merck &amp; Co. in which the New Jersey drug giant will pay $20 million cash and buy $10 million in stock for the rights to use Idera's immune-boosting technology in potential Merck vaccines. If the vaccines succeed, the deal could be worth up to $425 million in additional ...
200022
NEW YORK, Nov. 29 -- Drugmaker Merck & Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that would guarantee large severance packages to 230 top executives if the company merges or is taken over.
237168
Shares of Nastech Pharmaceutical Co.  Inc. NSTK.O jumped 23 percent before the bell on Monday after  the company said it tied up with Merck & Co. MRK.N to develop  and market Nastech's experimental nasal spray treatment for  obesity.
362899
Merck &amp; Co  agreed to pay more than $649 million to resolve litigation related to its cholesterol drug Zocor and painkiller Vioxx, a federal prosecutor said on Thursday.
272859
Genizon, a Canadian biotech company, gets an infusion of cash to develop personalized medicine for metabolic disorders, including obesity and diabetes.